Laura Adams, Senior Advisor, National Academy of Medicine
Laura Adams, Senior Advisor at the National Academy of Medicine (NAM), provides strategic leadership for the Science and Technology portfolio of the Leadership Consortium and leads the NAM’s Artificial Intelligence Code of Conduct (AICC) national initiative. Her expertise is in AI, digital health, and human-centered care. She is a member of the international AI Expert Panel for the Organization of Economic Co-operation and Development (OECD) and chairs the Global Opportunities Group for the AI Regulatory Science and Innovation Network in the UK.
Laura serves on the boards of Boston-based T2 Biosystems and TMA Precision Health; and is a strategic advisor for Inflammatix, a Burlingame, CA-based biotech company specializing in transcriptomics/host immune response diagnostics.
Laura chaired the Institute of Medicine’s (IOM) Planning Committee for the “Digital Infrastructure for the Learning Healthcare System” initiative. She is recognized as a strategic leader of large scale multisectoral initiatives with a deep experience in and understanding of the complex U.S. health care industry, including how the components function and interact.
Laura was among the first to bring the science of healthcare quality improvement to the Middle East, in conjunction with Donald Berwick, MD and the Harvard Institute for Social and Economic Policy in the Middle East. She served as Institute for Healthcare Improvement (IHI) faculty at the inaugural IHI Middle East Forum on Quality Improvement in Healthcare in Doha, Qatar.
Laura was founding President and CEO of the Rhode Island Quality Institute (RIQI), Rhode Island’s statewide health information exchange. Under her leadership, RIQI won the National Council for Community Behavioral Health Excellence Award for Impact in serving those with behavioral health and substance abuse challenges. RIQI was the recipient of the national Healthcare Informatics Innovation Award; and was a top finalist for the New England Business Innovation award for impact on the opioid crisis. Laura has delivered keynotes in nearly every state in the union and in 13 foreign countries.
